{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T13:37:03Z","timestamp":1786628223189,"version":"build-2736575974"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:p>\n                    Lichen sclerosus (LS) is a chronic inflammatory condition of the vulva. Although LS is thought to arise from autoimmune mechanisms, it is unclear whether disease drivers differ by menopausal status\u2014an important distinction given its potential progression to differentiated vulvar intraepithelial neoplasia (dVIN) and vulvar squamous cell carcinoma (VSCC). We performed a retrospective review of 182 biopsy-proven LS cases (2020\u20132025), stratified by menopause status. In addition, we examined 27 VSCC cases for PD-L1 staining to assess immune modulation and potential therapeutic relevance. Premenopausal patients were diagnosed at a much younger age (37.8 vs. 67.5\u00a0yr,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt;0.001) and experienced longer delays to diagnosis (3.9 vs. 1.5\u00a0yr,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt;0.001). Their biopsies were less often reported with definitive LS terminology (40% vs. 75%,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt;0.001), suggesting under-recognition in younger women. Comorbidities were more common in this group, especially autoimmune disease (46.7% vs. 10.9%,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt;0.001), whereas postmenopausal patients more frequently had atrophic vaginitis (15.9%,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.02). Progression to dVIN or VSCC occurred more often in postmenopause (13.1% vs. 8.9%), though this was not statistically significant. PD-L1 expression was frequent in VSCC and precursor lesions (HSIL: 80%; dVIN: 81%) and less common in LS (50%), though these differences were not statistically significant. Expression patterns varied by lesion type, suggesting potential differences in the local immune microenvironment. Taken together, these findings support differences in clinical presentation and immune features of LS by menopausal status, warranting further investigation in larger cohorts.\n                  <\/jats:p>","DOI":"10.1097\/pgp.0000000000001189","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T13:01:50Z","timestamp":1779973310000},"page":"333-339","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Clinicopathologic and Immunologic Features of Vulvar Lichen Sclerosus and Related Neoplasia: A Comparative Study of Precursor Lesions and VSCC in Premenopausal and Postmenopausal Patients"],"prefix":"10.1097","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9532-3248","authenticated-orcid":false,"given":"Elayna M.","family":"Shanker","sequence":"first","affiliation":[{"name":"NYU Langone Medical Center, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Moscona","sequence":"additional","affiliation":[{"name":"Northwell Health, New Hyde Park, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Chiriboga","sequence":"additional","affiliation":[{"name":"NYU Langone Medical Center, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Gonzales","sequence":"additional","affiliation":[{"name":"NYU Langone Medical Center, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Eden","sequence":"additional","affiliation":[{"name":"NYU Langone Medical Center, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Adler","sequence":"additional","affiliation":[{"name":"NYU Langone Medical Center, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"key":"R1-20260813","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s40257-012-0006-4","article-title":"Diagnosis and treatment of lichen sclerosus: an update","volume":"14","author":"Fistarol","year":"2013","journal-title":"Am J Clin Dermatol"},{"key":"R3-20260813","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.pathol.2016.02.015","article-title":"Squamous precursor lesions of the vulva: current classification and diagnostic challenges","volume":"48","author":"Hoang","year":"2016","journal-title":"Pathology"},{"key":"R4-20260813","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.ejca.2008.11.037","article-title":"Vulvar squamous cell carcinoma development after diagnosis of VIN increases with age","volume":"45","author":"van de Nieuwenhof","year":"2009","journal-title":"Eur J Cancer"},{"key":"R5-20260813","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0140-6736(03)13863-9","article-title":"Autoantibodies to extracellular matrix protein 1 in lichen sclerosus","volume":"362","author":"Oyama","year":"2003","journal-title":"Lancet"},{"key":"R6-20260813","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.7150\/ijbs.34613","article-title":"Lichen sclerosus: an autoimmunopathogenic and genomic enigma with emerging genetic and immune targets","volume":"15","author":"Tran","year":"2019","journal-title":"Int J Biol Sci"},{"key":"R7-20260813","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.3390\/diagnostics12123070","article-title":"Lichen sclerosus: a current landscape of autoimmune and genetic interplay","volume":"12","author":"Oyama","year":"2022","journal-title":"Diagnostics"},{"key":"R8-20260813","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1473-2165.2002.00406.x","article-title":"The Koebner phenomenon: review of the literature","volume":"16","author":"Weiss","year":"2002","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R9-20260813","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1396-0296.2004.04004.x","article-title":"Lichen sclerosus: a review and practical approach","volume":"17","author":"Funaro","year":"2004","journal-title":"Dermatol Ther"},{"key":"R10-20260813","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/his.12034","article-title":"Pathways of vulvar intraepithelial neoplasia and squamous cell carcinoma","volume":"62","author":"Del Pino","year":"2013","journal-title":"Histopathology"},{"key":"R11-20260813","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/01.pgp.0000177646.38266.6a","article-title":"Vulvar squamous cell carcinoma is a multifactorial disease following two separate and independent pathways","volume":"25","author":"van der Avoort","year":"2006","journal-title":"Int J Gynecol Pathol"},{"key":"R12-20260813","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/ijc.33198","article-title":"Vulvar intraepithelial neoplasia: incidence and long-term risk of vulvar squamous cell carcinoma","volume":"148","author":"Thuijs","year":"2021","journal-title":"Int J Cancer"},{"key":"R13-20260813","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00428-021-03070-0","article-title":"Histological interpretation of differentiated vulvar intraepithelial neoplasia (dVIN) remains challenging\u2014observations from a bi-national ring-study","volume":"479","author":"Dasgupta","year":"2021","journal-title":"Virchows Arch"},{"key":"R14-20260813","first-page":"727","article-title":"PD-1\/PD-L1 pathway: current researches in cancer","volume":"10","author":"Han","year":"2020","journal-title":"Am J Cancer Res"},{"key":"R15-20260813","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1001\/jamaoncol.2015.6326","article-title":"Genetic basis for PD-L1 expression in squamous cell carcinomas of the cervix and vulva","volume":"2","author":"Howitt","year":"2016","journal-title":"JAMA Oncol"},{"key":"R16-20260813","doi-asserted-by":"crossref","first-page":"89903","DOI":"10.18632\/oncotarget.20911","article-title":"PD-L1 expression on immune cells is a favorable prognostic factor for vulvar squamous cell carcinoma patients","volume":"8","author":"Sznurkowski","year":"2017","journal-title":"Oncotarget"},{"key":"R17-20260813","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1200\/JCO.18.00149","article-title":"Updated analysis of KEYNOTE-024: pembrolizumab versus platinum-based chemotherapy for advanced non\u2013small-cell lung cancer with PD-L1 tumor proportion score of 50% or greater","volume":"37","author":"Reck","year":"2019","journal-title":"J Clin Oncol"},{"key":"R18-20260813","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/S1470-2045(17)30690-3","article-title":"Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial","volume":"18","author":"Brahmer","year":"2017","journal-title":"Lancet Oncol"},{"key":"R19-20260813","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1200\/JCO.20.01888","article-title":"Randomized phase III KEYNOTE-181 study of pembrolizumab versus chemotherapy in advanced esophageal cancer","volume":"38","author":"Kojima","year":"2020","journal-title":"J Clin Oncol"},{"key":"R20-20260813","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/his.13723","article-title":"PD-L1 and IDO expression in cervical and vulvar invasive and intraepithelial squamous neoplasias: implications for combination immunotherapy","volume":"74","author":"Chinn","year":"2019","journal-title":"Histopathology"},{"key":"R21-20260813","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/jid.2011.369","article-title":"An autoimmune phenotype in vulvar lichen sclerosus and lichen planus: a Th1 response and high levels of microRNA-155","volume":"132","author":"Terlou","year":"2012","journal-title":"J Invest Dermatol"},{"key":"R22-20260813","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00403-024-02838-z","article-title":"Assessment of PD-1 and PD-L1 tissue expression levels in lichen planus patients: a case\u2013control study","volume":"316","author":"Elmasry","year":"2024","journal-title":"Arch Dermatol Res"},{"key":"R23-20260813","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1111\/exd.14660","article-title":"Differential proteomic expression in indolent vulvar lichen sclerosus, transforming vulvar lichen sclerosus and normal vulvar tissue","volume":"31","author":"Gleue","year":"2022","journal-title":"Exp Dermatol"},{"key":"R24-20260813","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/j.jid.2024.01.027","article-title":"Assessment of the cutaneous hormone landscapes and microbiomes in vulvar lichen sclerosus","volume":"144","author":"Pyle","year":"2024","journal-title":"J Invest Dermatol"},{"key":"R25-20260813","doi-asserted-by":"crossref","first-page":"1106318","DOI":"10.3389\/fmed.2023.1106318","article-title":"Lichen sclerosus: the 2023 update","volume":"10","author":"De Luca","year":"2023","journal-title":"Front Med"},{"key":"R26-20260813","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/aji.12532","article-title":"Menopausal status influences the expression of programmed death (PD)-1 and its ligand PD-L1 on immune cells from the human female reproductive tract","volume":"76","author":"Shen","year":"2016","journal-title":"Am J Reprod Immunol"},{"key":"R27-20260813","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1080\/01478885.2020.1823105","article-title":"Validation of PD-L1 clone 22C3 immunohistochemical stain on two Ventana DISCOVERY autostainer models: detailed protocols, test performance characteristics, and interobserver reliability analyses","volume":"43","author":"Basu","year":"2020","journal-title":"J Histotechnol"},{"key":"R28-20260813","doi-asserted-by":"crossref","first-page":"104105","DOI":"10.1016\/j.labinv.2025.104105","article-title":"Monitoring immunohistochemical staining variations by artificial intelligence on standardized controls","volume":"105","author":"van Kempen","year":"2025","journal-title":"Lab Invest"},{"key":"R29-20260813","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.5858\/arpa.2022-0088-OA","article-title":"Interobserver agreement across subspecialties for diagnosis of differentiated vulvar intraepithelial neoplasia and predictive values of 20 histologic features","volume":"147","author":"Schechter","year":"2023","journal-title":"Arch Pathol Lab Med"},{"issue":"suppl 1","key":"R30-20260813","doi-asserted-by":"crossref","first-page":"bjgp24X737961","DOI":"10.3399\/bjgp24X737961","article-title":"Barriers to identifying, diagnosing, and treating vulval lichen sclerosus in primary care: a mixed methods survey study","volume":"74","author":"Clarke","year":"2024","journal-title":"Brit J Gen Pract"}],"container-title":["International Journal of Gynecological Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/PGP.0000000000001189","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T13:01:16Z","timestamp":1786626076000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/PGP.0000000000001189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/pgp.0000000000001189","relation":{},"ISSN":["0277-1691","1538-7151"],"issn-type":[{"value":"0277-1691","type":"print"},{"value":"1538-7151","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]},"assertion":[{"value":"2025-12-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}